Narrow Results

The article is about the story of the Singapore Research Institute and the research in ophthalmology in the Asia Pacific region.

Problems Faced in the Expansion of China’s Health Supplementary Products Market.

India: Popular Destination for Biotech Industry Investment in Asia Pacific.

Singapore’s Growing Biomedical Sector.

Competitive Positioning Strategies for Australian Biotech Companies.

CardioMonitor Launched in Asia Pacific.

The article is a short overview of the biotech industry in Singapore.

Indian Pharma Industry: Trends, Predictions and Challenges.

Imaging in Focus.

Technology Innovation to Drive Efficiency: Unprecedented Transformation in Care Delivery Across Asia Pacific.

Providing for Emerging Markets: A Chat with Raman Singh from Mundipharma.

GE Healthcare Life Sciences take part in Life-Saving, Olivier Loeillot (GM of Bioprocess Asia).

Cennerv Pharma: A Company that Fights Along with Mental Illnesses.

How Can Cord Blood be Used to Save Lives? Life-Saving Mission of SCBB: An Interview with Dr. William Hwang.

An Interview with Mr. Stephen Ooi, Senior Executive Advisor Zimmer Biomet Asia Pacific.

APACMed – Serving Unmet Healthcare Needs in Asia Pacific, Fredrik Nyberg (CEO of APACMed).

Vaccination, One of the Solutions to Prevent Dengue Infection.

MonaLisa Touch^® Advanced Laser Treatment for Better Life Quality.

Cervical Cancer is Highly Preventable. Don’t Succumb to It.

Do Your Part to Stop Infectious Disease from Spreading: Insights from Infectious Diseases Expert — Dr. Leong Hoe Nam.

Infectious Diseases in Asia Pacific: Top Five Targets for Prophylaxis Vaccines.

Kantar Health in Healthcare.

Saphetor: Leader of the Revolution in Clinical Diagnostics.

Healthcare Advancement: “Healthcare is a National Right, Not a Privilege”.

Data Showed Treatment Makes mCRPC Patients Live Longer.

BIOTRONIK Begins Manufacturing High-Tech Products in Singapore.

First Dengue Vaccine Approved in More than 10 Countries.

Zyrtec^® Tablet for Allergy Relief, Now Available Over-the-Counter as Zyrtec^®-R Tablet.

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running.

First Pan-Asian Real-world Study on the Use of Rivaroxaban for Stroke Prevention in Patients with Atrial Fibrillation.

Oxford Spinout to Develop Cancer Therapies which Reprogram Tumours to Die.

Recruitment Begins for Major Clinical Study in Precision Therapy for Liver Cancer Patients.

GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea.

Regional Experts Urging Stakeholder Collaboration to Address Burden of Osteoporosis at IOF 6th Asia-Pacific Meeting

Cardinal Health Announces New Strategic Distribution Agreements to Expand Cordis’ Cardiovascular Product Offerings in Asia Pacific

Exco InTouch Granted US Patent for Its Ground-breaking Mobile Health Solutions

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

Singapore's Restalyst Develops More Effective Test Kit for Liver Cancer

Bayer Collaborates with Singapore National Eye Centre to Take the Lead in Professional Development of Ophthalmologists Across Asia

Partnerships and Innovation: Shaping the Future of Healthcare in Asia Pacific

Chugai's Novel Antibody Technologies Put Singapore at the Centre of Fight Against Disease

NCCS AND SGH Conducts Systematic Molecular Profiling of Lung Cancers to Identify New Treatment Opportunities

APACMed in MedTech Industry – Insights from Brent Scott

L’Oréal Supports Women Contributing in Science Industry

Mab-Venture Biopharma & Thermo Fisher Establish Asia Pacific’s First “SmartFactory” for Antibody Drugs.

Venus Medtech’s TAVR Device Is Approved By CFDA, Creating A New Era of Interventional Cardiology in China.

Key Diabetes Receptor Structure Determined by International Collaboration.

China Sets Up National Lab Developing Brain-Like AI Technology.

Chinese Scientists Realize On-site Drug Detection.

Scientists Map Single-Copy HIV-1 Provirus Loci in Human Chromosomes in Live Host Cells.

Gene Variant Explains Differences in Blood Fatty Acid Levels.

Scientists Illustrate How Host Cell Responds to Zika Virus Infection.

Hong Kong News – Uni-Bio Science Launches Best-in-Class Oral Anti-Diabetic Drug Mitiglinide Branded “博康泰^®”(Bokangtai).

NUS Researchers Create Palm-Size Device for Quick, Effective Treatment of Common Hearing Disorder.

World Asthma Day: Managing and Living with Asthma.

DARZALEX^® (daratumumab) Available in Singapore, Following Accelerated Approval by the Health Sciences Authority.

Managing Liver Cancer as a Global Health Problem.

Bayer and NUS Enterprise Announce Winners of Grants4Apps^® Singapore Open Innovation Challenge.

Exclusive Interviews with the Grants4Apps^® winners: I. EyeDEA, Singapore, II. GlycoLeap by Holmusk, Singapore and III. PillPocket, Thailand.

JAPAN – Asia Pacific Medical Technology Association (APACMed) announces partnership with Japan Federation of Medical Devices Associations (JFMDA).

UNITED STATES – Gene Mutation May Speed Up Memory Loss in Alzheimer’s Disease.

UNITED STATES – Know the Facts About Skin Cancer.

UNITED STATES – Another Reason to Exercise: Burning Bone Fat – a Key to Better Bone Health.

AUSTRALIA & NEW ZEALAND – LCT Collaborates with Auckland University Centre for Brain Research to Extend Product Pipeline.

TAIWAN – Peptide Nasal Spray to Delay Onset of Alzheimer’s disease.

TAIWAN – TLC178 Designated by US FDA as Drug for Rare Pediatric Disease in the Treatment of Rhabdomyosarcoma.

SINGAPORE – Asia Pacific Medical Technology Association (APACMed) Announces Partnership with Duke-NUS Medical School’s Centre of Regulatory Excellence (CoRE), Pledging Joint Commitment to Promote Regulatory Convergence and Capacity Building Across the Region.

SINGAPORE – Guardian Partners with MyDoc to Address Singapore’s Population Health Needs through Integrating Technology and Self-Care.

SINGAPORE & UNITED STATES – CellMax Life’s Precision, Non-Invasive Cancer Testing Now Available throughout Southeast Asia through Asia Genomics.

UNITED STATES – 3-D Printed Models Could Improve Patient Outcomes in Heart Valve Replacements.

UNITED STATES – Promising Target to Protect Bone in Patients with Diabetes.

UNITED STATES – New Antibody Appears to Re-Activate Immune System in Cancer Therapy.

UNITED STATES – Combo Immunotherapy May Herald New Standard of Care for Kidney Cancer.

JAPAN – Chugai’s Bispecific Antibody “Emicizumab” Global Phase III Data in Patients with Haemophilia A with Inhibitors Published in The New England Journal of Medicine Online.

RUSSIA & INDIA – BIOCAD’s Rituximab Biosimilar to Receive Market Authorization Soon in India.

APAC drug delivery devices market to reach $5.4 billion in 2023.

Mergermarket released Global Pharma, Medical & Biotech trend report for Q3 2017.

Global BioLife develops breakthrough modified sugar.

Breakthrough noodle formula with low-glycemic score of 38.

Aphria ships first medical cannabis oil to Australia’s Medlab for clinical trial.

Envirotainer doubles e-technology capacity across Asia.

Genesis CancerCare Queensland is first in Asia-Pacific to use Elekta’s Venezia Brachytherapy Applicator.

iX Biopharma secures European patent for WaferiX drug delivery technology.

Shingrix approved in the US for prevention of shingles in adults aged 50 and over.

First three-monthly long-acting treatment for schizophrenia patients in Singapore.

China, Brazil and Russia named by healthcare companies as riskiest markets for compliance and regulation.

New survey shows patients in Asia Pacific fail to recognize their fragility fracture is due to osteoporosis.

Healthcare community join forces to fight growing epidemic of fragility fractures caused by osteoporosis.

Healthcare heads into the digital future.

Digital technology improves research and management of functional gastrointestinal disorders in babies.

Welcome to the healthcare revolution.

Doctor Robot will see you now.

Maximising human potential in the age of AI.

The Internet of Things in healthcare - A double-edged sword?.

Data could help Asia cope with its ageing population.

A vision of connected healthcare delivery in Asia.

The following topics are under this section:

• Australian medical life sciences company expands nutraceutical business to the USA
• First Amgen Scholars Asia Symposium in Singapore held by Amgen Foundation
• Breakthrough study by world leader in meat-free food finds alternative source of protein to milk protein
• Meeting the need for Surgical Site Infection Prevention in the Asia Pacific
• Patient intelligence company raises US$13 million, taking its AI-powered doctor discovery platform global
• New study reveals top health and nutrition priorities for children, according to Mothers across Asia Pacific
• Entity Health launches new supplement targeted as a defence against progression to Type 2 Diabetes
• Xylonix collaborates with BioGemex to develop novel pre-treatment point-of-care diagnostic
• Imagion Biosystems initiates regulatory communications for first-in-human study

Background: ASPIRE (Asia-Pacific Initiative on Reproduction) aims to develop a “patient-centered” guide to provide fertility treatment based on patient preferences, needs, and concerns during and beyond the SARS-Cov-2 pandemic.

Methods: Women, aged 20–45 years old, trying to conceive for more than 6 months and contemplating for pregnancy including IVF treatment. A country wise analysis of patient behavior, attitudes and concerns, reasons for disruption of treatment and availability of assistance from fertility clinics during SARS-Cov-2 pandemic was performed. Six problem statements addressing patient concerns were identified and corresponding solutions to improve patient experience were formulated. A two-tier recommendation was developed. Tier 1 comprises recommendations in which the rate of “absolutely agree” responses were $\ge$60%, whereas tier 2 refers to recommendations in which the rate of “absolutely agree” plus “agree” together was >60%.

Results: Women in countries that have better infection control and are living a new normal were less worried about the pandemic influencing their lifestyle and finances. The proportion of women choosing not to continue IVF/IUI treatment during COVID-19 was similar across countries. Sixty-five percent of women in Group A intend to continue treatment during COVID-19 pandemic. Nine out of 10 patients are expected to resume or start treatment once fertility clinics are accessible. A patient-centered guide focusing on management of patient safety concerns, reduction in difficulty of access to hospitals, prioritization of patients, provision of emotional support, and improvement in patient education and acceptance of remote health services was developed.

Conclusion: This ASPIRE patient experience report highlights a patient-centered guide on provision of safe fertility treatment across the Asia-Pacific region, which can be adapted to suit country-specific requirements depending on the stage of the pandemic, local restrictions, and availability of resources.